Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Rybelsus“
Suchtreffer
Begriffe & Kennungen
Rybelsus · 4.8 · 9 section 4.4.). In phase 3b cardiovascular outcomes trial SOUL, the frequency of acute pancreatitis confirmed
Eintrag öffnenRybelsus · 4.8 · Acute pancreatitis confirmed by adjudication has been reported in phase 3a trials, semaglutide (< 0.1%) and co
Eintrag öffnenRybelsus · 4.8 · Acute pancreatitis confirmed by adjudication has been reported in phase 3a trials, semaglutide (< 0.1%) and co
Eintrag öffnenRybelsus · 4.8 · Description of selected adverse reactions
Eintrag öffnenRybelsus · 4.8 · Description of selected adverse reactions
Eintrag öffnenRybelsus · 4.8 · Diabetic retinopathy complications A 2-year clinical trial with subcutaneous semaglutide investigated 3 297 pa
Eintrag öffnenRybelsus · 4.8 · Dysaesthesia Events related to a clinical picture of altered skin sensation such as paraesthesia, pain of skin
Eintrag öffnenRybelsus · 4.8 · Dysaesthesia Events related to a clinical picture of altered skin sensation such as paraesthesia, pain of skin
Eintrag öffnenRybelsus · 4.8 · Gastrointestinal adverse reactions Nausea occurred in 15%, diarrhoea in 10%, and vomiting in 7% of patients wh
Eintrag öffnenRybelsus · 4.8 · Gastrointestinal adverse reactions Nausea occurred in 15%, diarrhoea in 10%, and vomiting in 7% of patients wh
Eintrag öffnenRybelsus · 4.8 · Heart rate increase Increased heart rate has been observed with GLP-1 receptor agonists. In the phase 3a trial
Eintrag öffnenRybelsus · 4.8 · Heart rate increase Increased heart rate has been observed with GLP-1 receptor agonists. In the phase 3a trial
Eintrag öffnenRybelsus · 4.8 · Hypoglycaemia Severe hypoglycaemia was primarily observed when semaglutide was used with a sulfonylurea (< 0.1
Eintrag öffnenRybelsus · 4.8 · Hypoglycaemia Severe hypoglycaemia was primarily observed when semaglutide was used with a sulfonylurea (< 0.1
Eintrag öffnenRybelsus · 4.8 · Immunogenicity Consistent with the potential immunogenic properties of medicinal products containing proteins
Eintrag öffnenRybelsus · 4.8 · Immunogenicity Consistent with the potential immunogenic properties of medicinal products containing proteins
Eintrag öffnenRybelsus · 4.8 · In 10 phase 3a trials, 5 707 patients were exposed to semaglutide alone or in combination with other glucose-l
Eintrag öffnenRybelsus · 4.8 · In 10 phase 3a trials, 5 707 patients were exposed to semaglutide alone or in combination with other glucose-l
Eintrag öffnenRybelsus · 4.8 · In PIONEER PLUS when treated with semaglutide 25 mg and 50 mg nausea occurred in 27% and 27%, diarrhoea in 13%
Eintrag öffnenRybelsus · 4.8 · In PIONEER PLUS when treated with semaglutide 25 mg and 50 mg nausea occurred in 27% and 27%, diarrhoea in 13%
Eintrag öffnen